Global Metal Non-Covered Biliary Stent Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

The type segment of the metal non-covered biliary stent market includes options such as self-expanding metal stents (SEMS) and balloon-expandable stents. SEMS are the most widely used type due to their ability to expand automatically once deployed, providing a more secure and long-lasting solution for bile duct obstruction. Balloon-expandable stents, though less common, are used in specific cases requiring precise placement and controlled expansion. The growing adoption of SEMS is driven by their effectiveness in treating benign and malignant biliary strictures, as well as their relatively lower complication rates compared to other stent types. The type of stent used depends on the severity and location of the obstruction, as well as the patient’s overall health condition.

In the application segment, metal non-covered biliary stents are used in both benign and malignant biliary obstructions. Malignant biliary obstructions, often caused by cancers such as pancreatic, bile duct, and gallbladder cancer, represent a significant portion of the market due to the growing incidence of these cancers globally. Metal non-covered stents provide an effective means of relieving obstructed bile flow in patients with advanced cancers. On the other hand, benign biliary obstructions, typically caused by conditions like chronic pancreatitis, bile duct stones, or strictures, also benefit from the use of these stents. The demand for metal non-covered biliary stents in both types of applications is expanding due to the increasing prevalence of conditions that lead to biliary obstructions and advancements in endoscopic procedures.

The end user segment includes hospitals, specialized clinics, and ambulatory surgical centers (ASCs). Hospitals are the largest end users of metal non-covered biliary stents, primarily due to the need for comprehensive treatment options and the presence of advanced medical infrastructure. Hospitals provide specialized care for patients with complex biliary diseases, particularly those with malignant obstructions requiring stent placement as part of palliative care. Specialized clinics and ASCs are also seeing increased demand for biliary stenting procedures, especially in less complex cases or outpatient settings. ASCs offer a more cost-effective solution for patients requiring routine procedures and shorter recovery times.

Overall, the global metal non-covered biliary stent market continues to expand as advancements in stent technology improve treatment outcomes and reduce complications. The growing prevalence of biliary diseases and the need for minimally invasive procedures are key drivers in the market’s development. Each segment within the market plays a critical role in ensuring effective management of biliary obstructions across diverse patient populations.

Global Metal Non-Covered Biliary Stent Segment Analysis

In this report, the Global Metal Non-Covered Biliary Stent Market has been segmented by Type, Application, End User and Geography.

Global Metal Non-Covered Biliary Stent Market, Segmentation by Type

The Global Metal Non-Covered Biliary Stent Market has been segmented by Type into Adsorbable and Non-adsorbable.

Adsorbable biliary stents represent a burgeoning segment within the market, characterized by their biodegradable properties that facilitate gradual absorption and elimination from the body over time. These stents offer several advantages, including reduced risk of long-term complications such as stent migration, tissue overgrowth, and recurrent biliary obstruction. Additionally, adsorbable stents obviate the need for additional interventions for stent removal, minimizing patient discomfort and healthcare resource utilization. As a result, they are increasingly preferred in certain clinical scenarios, particularly in the management of benign biliary strictures and postsurgical complications where short to medium-term stent placement is indicated.

In contrast, non-adsorbable biliary stents comprise the traditional segment of the market, encompassing stents fabricated from durable metals such as stainless steel, nitinol, or cobalt-chromium alloys. These stents are designed to provide long-term structural support to the bile ducts, maintaining patency and facilitating bile drainage in cases of malignant strictures and advanced biliary diseases. Non-adsorbable stents are characterized by their high radial force, flexibility, and resistance to degradation, making them suitable for prolonged indwellment in challenging clinical conditions. Despite their permanence within the body, non-adsorbable stents may require periodic replacement due to potential complications such as stent occlusion, tissue ingrowth, or stent-related infections.

Global Metal Non-Covered Biliary Stent Market, Segmentation by Application

The Global Metal Non-Covered Biliary Stent Market has been segmented by Application into Malignant Obstruction, Biliary Leaks, Benign Biliary Strictures, and Others.

Malignant obstruction stands as a primary application area for metal non-covered biliary stents, encompassing cases where tumors or cancerous growths impede bile flow within the biliary tract. These stents serve a crucial role in providing palliative care by relieving obstructive symptoms, such as jaundice and cholangitis, and improving patient comfort and quality of life. Metal stents are preferred in malignant obstructions due to their high radial force and durability, offering long-term patency and minimizing the need for frequent stent exchanges or replacements.

Biliary leaks represent another important application for metal non-covered biliary stents, occurring as a result of trauma, iatrogenic injury, or surgical complications affecting the biliary system. In such cases, stent placement serves to divert bile flow away from the site of leakage, promoting healing and preventing the accumulation of bile in surrounding tissues or cavities. Metal stents offer advantages in terms of structural integrity and resistance to migration, making them effective in sealing off biliary leaks and facilitating tissue repair.

Benign biliary strictures constitute a significant indication for metal non-covered biliary stents, encompassing non-malignant narrowing of the bile ducts due to inflammatory, infectious, or postsurgical causes. These strictures may result in bile duct obstruction, recurrent cholangitis, or biliary cirrhosis, necessitating interventions to restore bile flow and alleviate symptoms. Metal stents provide durable support and maintain patency in the presence of benign strictures, offering long-term relief and reducing the need for repeated interventions.

Beyond these primary applications, metal non-covered biliary stents find utility in addressing various other clinical indications within the biliary tract, including pancreatitis, bile duct stones, and complications of biliary surgery or endoscopic interventions. In each case, stent placement aims to alleviate symptoms, promote bile drainage, and prevent further complications, contributing to improved patient outcomes and enhanced quality of care.

Global Metal Non-Covered Biliary Stent Market, Segmentation by End User

The Global Metal Non-Covered Biliary Stent Market has been segmented by End User into Hospitals, Clinics, and Ambulatory Surgical Centers.

Hospitals are the largest end user of metal non-covered biliary stents. They offer comprehensive healthcare services, including specialized care for patients with severe or complex biliary obstructions, often resulting from malignancies such as bile duct or pancreatic cancer. The demand for non-covered biliary stents in hospitals is driven by their need to manage both benign and malignant conditions effectively. Hospitals provide a full range of diagnostic tools, advanced medical procedures, and post-procedure care, which makes them essential in treating patients requiring long-term solutions for biliary obstruction. The higher complexity of cases typically seen in hospitals, as well as the availability of skilled healthcare professionals and advanced equipment, make them a primary setting for biliary stenting procedures.

Clinics, including specialized gastroenterology and hepatology clinics, also represent a significant end user segment in the market. These clinics often handle less complex cases of biliary obstruction, such as benign strictures caused by chronic pancreatitis or gallstones. The increasing demand for minimally invasive procedures and the shift toward outpatient care have contributed to the growth of biliary stent use in clinics. Non-covered biliary stents are favored for their cost-effectiveness and efficiency in treating non-malignant conditions, allowing clinics to provide high-quality care while maintaining a more streamlined and cost-efficient approach.

Ambulatory surgical centers (ASCs) are becoming increasingly important in the metal non-covered biliary stent market. These facilities focus on outpatient surgeries, offering patients a lower-cost, more convenient option for procedures that don't require an overnight hospital stay. ASCs are equipped to perform routine stenting procedures for benign biliary obstructions and offer patients a faster recovery time compared to hospitals. The growing preference for outpatient procedures and the rising number of minimally invasive surgeries are driving the adoption of non-covered biliary stents in these settings, especially for patients with less severe or chronic biliary issues.

Each of these end users—hospitals, clinics, and ASCs—contributes to the overall growth of the metal non-covered biliary stent market by addressing the varying needs of patients with biliary obstructions, from complex, life-threatening conditions to routine, outpatient procedures.

Global Metal Non-Covered Biliary Stent Market, Segmentation by Geography

In this report, the Global Metal Non-Covered Biliary Stent Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Global Metal Non-Covered Biliary Stent Market Share (%), by Geographical Region, 2024

North America stands as a prominent region in the metal non-covered biliary stent market, driven by robust healthcare systems, high prevalence of biliary disorders, and advanced medical technologies. The region boasts significant market share, with the United States leading in terms of healthcare expenditure, research and development investments, and adoption of minimally invasive procedures. Favorable reimbursement policies and a strong regulatory framework contribute to the widespread adoption of metal non-covered biliary stents across various clinical settings.

Europe represents another major market for metal non-covered biliary stents, characterized by a diverse healthcare landscape encompassing both publicly funded and private healthcare systems. Countries such as Germany, France, and the United Kingdom exhibit high demand for biliary interventions, fueled by aging populations, increasing incidence of biliary diseases, and rising awareness of minimally invasive treatment options. Regulatory harmonization within the European Union streamlines market access for manufacturers, facilitating product launches and innovation initiatives.

The Asia Pacific region presents significant growth opportunities for the metal non-covered biliary stent market, fueled by rapid urbanization, improving healthcare infrastructure, and expanding access to medical services. Countries such as China, Japan, and India witness increasing adoption of advanced medical technologies, driven by rising healthcare expenditure and growing demand for minimally invasive procedures. Market dynamics vary across countries due to differences in disease prevalence, healthcare policies, and economic development levels.

In the Middle East and Africa region, market growth is driven by improving healthcare infrastructure, increasing investment in medical technology, and rising prevalence of biliary diseases. Countries such as the United Arab Emirates, Saudi Arabia, and South Africa exhibit growing demand for biliary interventions, driven by factors such as lifestyle changes, epidemiological transitions, and increasing access to healthcare services. Market penetration may be hindered by challenges related to healthcare access, affordability, and regulatory barriers.

Latin America represents a dynamic market for metal non-covered biliary stents, characterized by a mix of public and private healthcare systems, varying levels of economic development, and diverse disease burdens. Countries such as Brazil, Mexico, and Argentina exhibit growing demand for biliary interventions, driven by factors such as population growth, aging demographics, and increasing prevalence of biliary diseases. Market growth may be tempered by challenges such as healthcare disparities, regulatory complexities, and economic instability.

This report provides an in depth analysis of various factors that impact the dynamics of Global Metal Non-Covered Biliary Stent Market. These factors include; Market Drivers, Restraints, and Opportunities.

Drivers:

• Increasing prevalence of biliary disorders
• Surge in minimally invasive procedures
• Aging global population
• Favorable reimbursement policies

• Demand for long-term palliative care solutions - The increasing demand for long-term palliative care solutions serves as a significant driver in propelling the growth of the global metal non-covered biliary stent market. Palliative care plays a crucial role in enhancing the quality of life for patients suffering from advanced biliary tract disorders, particularly those with malignant obstructions or terminal illnesses. Metal non-covered biliary stents offer a palliative treatment option by providing durable structural support to the bile ducts, thereby relieving obstructive symptoms such as jaundice, pain, and cholangitis.

  One of the key drivers behind the demand for long-term palliative care solutions is the aging global population. As populations age, the prevalence of chronic and degenerative diseases, including biliary tract disorders, tends to increase. Elderly patients often present with complex medical conditions that may not be amenable to curative treatments, necessitating palliative interventions to manage symptoms and improve overall well-being. Metal non-covered biliary stents provide a minimally invasive and effective means of palliation, allowing patients to maintain a better quality of life and dignity during their remaining time.

  The rising incidence of biliary malignancies underscores the importance of palliative care solutions in addressing the unique needs of cancer patients. Malignant obstructions within the biliary tract can lead to debilitating symptoms and complications, significantly impacting patients' comfort and quality of life. Metal non-covered biliary stents offer a palliative approach by restoring bile flow, alleviating symptoms, and prolonging survival in patients with advanced disease stages. This demand for palliative care solutions is expected to grow as cancer incidence rates continue to rise globally.

Restraints:

• Stringent regulatory approval
• Stent-related complications risk
• Limited skilled healthcare workforce
• Durability and efficacy concerns

• Ethical dilemmas in end-of-life care - Ethical dilemmas in end-of-life care present a notable restraint within the global metal non-covered biliary stent market. As patients with advanced biliary tract disorders reach the end stages of their illness, healthcare providers are often faced with difficult decisions regarding treatment options and goals of care. Metal non-covered biliary stents are frequently used in palliative care settings to alleviate symptoms and improve quality of life. Ethical considerations arise concerning the appropriateness and timing of interventions, particularly when patients have limited life expectancy or poor prognosis.

  One of the key ethical dilemmas involves balancing the benefits and burdens of treatment for patients nearing the end of life. While metal non-covered biliary stents can provide effective symptom relief and prolong survival in some cases, the invasive nature of the procedure and potential risks associated with stent placement must be carefully weighed against the patient's overall prognosis and quality of life. Healthcare providers must consider whether the potential benefits of stent placement outweigh the risks and potential harms, taking into account the patient's values, preferences, and goals of care.

  Ethical considerations arise regarding patient autonomy and decision-making capacity in end-of-life care scenarios. Patients with advanced biliary diseases may face difficult decisions regarding their treatment options, including whether to undergo invasive interventions such as stent placement. Healthcare providers must engage in open and honest discussions with patients and their families, providing them with the information and support needed to make informed decisions that align with their values and wishes. Respect for patient autonomy requires healthcare providers to acknowledge and honor patients' choices regarding their end-of-life care preferences, even if these decisions involve forgoing or discontinuing certain treatments.

Opportunities:

• Adoption of value-based healthcare
• Integration of digital health solutions
• Tailored product offerings
• Physician training investments

• Patient-centric services development - Patient-centric services development presents a compelling opportunity within the global metal non-covered biliary stent market. As healthcare systems increasingly prioritize patient-centered care, there is growing recognition of the importance of tailoring services and support programs to meet the unique needs and preferences of patients with biliary tract disorders. Patient-centric services development encompasses a range of initiatives aimed at enhancing the overall patient experience, improving treatment outcomes, and empowering patients to actively participate in their care journey.

  One key aspect of patient-centric services development involves providing comprehensive education and support to patients and their caregivers. Many patients undergoing metal non-covered biliary stent placement may have limited understanding of their condition, treatment options, and self-care strategies. Patient education programs can empower patients with the knowledge and skills needed to manage their condition effectively, including information on dietary modifications, symptom management, and when to seek medical attention. By equipping patients with the necessary resources and support, healthcare providers can enhance treatment adherence, reduce complications, and improve overall patient satisfaction.

  Patient-centric services development includes initiatives aimed at improving communication and shared decision-making between patients and healthcare providers. Open and transparent communication is essential in ensuring that patients feel heard, valued, and respected throughout their care journey. Healthcare providers should engage patients in meaningful discussions about their treatment goals, preferences, and concerns, involving them as active partners in decision-making processes. Shared decision-making promotes a collaborative approach to care that aligns with patients' values and preferences, leading to more personalized and patient-centered treatment plans.

Key players in Global Metal Non-Covered Biliary Stent Market include,

• Boston Scientific Corporation
• Cook Medical LLC
• Medtronic PLC
• C. R. Bard, Inc. (acquired by Becton, Dickinson and Company)
• Taewoong Medical Co., Ltd.
• CONMED Corporation
• Biotronik SE & Co. KG
• EndoChoice Holdings, Inc. (acquired by Boston Scientific Corporation)
• Merit Medical Systems, Inc.
• ELLA-CS, s.r.o.
• E.M.S. Electro Medical Systems S.A.
• Micro-Tech (Nanjing) Co., Ltd.
• Hobbs Medical, Inc.
• Stryker Corporation
• Olympus Corporation

In this report, the profile of each market player provides following information:

• Company Overview and Product Portfolio
• Key Developments
• Financial Overview
• Strategies
• Company SWOT Analysis